Short Interest in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Rises By 47.9%

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 1,755,818 shares, a growth of 47.9% from the December 15th total of 1,187,068 shares. Based on an average trading volume of 310,403 shares, the days-to-cover ratio is currently 5.7 days. Approximately 0.3% of the shares of the company are short sold. Approximately 0.3% of the shares of the company are short sold. Based on an average trading volume of 310,403 shares, the days-to-cover ratio is currently 5.7 days.

Analyst Ratings Changes

A number of research analysts have recently commented on FMS shares. Zacks Research lowered Fresenius Medical Care AG & Co. KGaA from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 4th. UBS Group cut shares of Fresenius Medical Care AG & Co. KGaA from a “sell” rating to an “underperform” rating in a research note on Wednesday, October 15th. Weiss Ratings downgraded shares of Fresenius Medical Care AG & Co. KGaA from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 5th. Truist Financial set a $28.00 price objective on shares of Fresenius Medical Care AG & Co. KGaA in a report on Monday, January 5th. Finally, Wall Street Zen upgraded shares of Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 20th. Three research analysts have rated the stock with a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and an average target price of $28.00.

Fresenius Medical Care AG & Co. KGaA Price Performance

Shares of NYSE FMS traded up $0.37 during midday trading on Friday, reaching $22.00. The company’s stock had a trading volume of 1,845,082 shares, compared to its average volume of 393,797. The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. The company has a 50 day moving average price of $23.42 and a 200 day moving average price of $25.07. Fresenius Medical Care AG & Co. KGaA has a one year low of $21.02 and a one year high of $30.46. The company has a market cap of $12.91 billion, a price-to-earnings ratio of 16.06, a price-to-earnings-growth ratio of 0.70 and a beta of 0.90.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last issued its earnings results on Tuesday, November 4th. The company reported $0.64 earnings per share for the quarter, topping analysts’ consensus estimates of $0.59 by $0.05. The firm had revenue of $5.73 billion during the quarter, compared to analysts’ expectations of $4.72 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 3.72% and a return on equity of 7.42%. On average, equities research analysts expect that Fresenius Medical Care AG & Co. KGaA will post 1.51 EPS for the current year.

Institutional Investors Weigh In On Fresenius Medical Care AG & Co. KGaA

A number of institutional investors and hedge funds have recently modified their holdings of the stock. TD Waterhouse Canada Inc. acquired a new position in shares of Fresenius Medical Care AG & Co. KGaA in the 2nd quarter valued at $36,000. CIBC Private Wealth Group LLC lifted its stake in Fresenius Medical Care AG & Co. KGaA by 398.2% during the third quarter. CIBC Private Wealth Group LLC now owns 1,380 shares of the company’s stock valued at $36,000 after buying an additional 1,103 shares in the last quarter. Atlantic Union Bankshares Corp acquired a new position in shares of Fresenius Medical Care AG & Co. KGaA in the second quarter worth about $43,000. Hantz Financial Services Inc. boosted its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 568.5% in the second quarter. Hantz Financial Services Inc. now owns 2,079 shares of the company’s stock worth $59,000 after buying an additional 1,768 shares during the period. Finally, Huntington National Bank increased its position in shares of Fresenius Medical Care AG & Co. KGaA by 219.5% in the second quarter. Huntington National Bank now owns 2,355 shares of the company’s stock worth $67,000 after acquiring an additional 1,618 shares in the last quarter. 8.37% of the stock is owned by institutional investors and hedge funds.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.